Androgenic Alopecia Clinical Trial
Official title:
The Use of Hydradermabrasion in the Scalp to Improve Scalp Health and Improve Outcomes in Androgenetic Alopecia
The study will be focused on evaluating the use of hydradermabrasion on the scalp. The study aims to assess the effect of this treatment on scalp health and hair growth.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | April 21, 2025 |
Est. primary completion date | April 21, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Participants who can give voluntary, written informed consent to participate in this study and from whom consent has been obtained including HIPAA Authorization - Participants who have androgenetic alopecia - Healthy men and women, ages 18 - 65 years of age - Participants who understand the study and can follow study instructions and are willing to attend the required study visits - Participants who agree to be photographed for research purposes and their identity may not be concealed in these photographs. - Participants who agree to continue their same treatment they are on at the baseline visit for androgenetic alopecia, for the entire duration of the study without plans to stop, change or add additional treatments. - Participants who agree to use the same shampoo for the duration of the study Exclusion Criteria: - Participants who have not had a change to hair loss treatment for 4 months prior to study enrollment - Participants who have an active or known skin inflammation or infection within the treatment area. - Participants who have an active or known acute skin allergies - Participants who have any other scalp conditions including eczema, psoriasis, infection, or scars within the treatment area - Participants of child-bearing potential who are not using an approved method of birth control (oral contraceptives, IUD, contraceptive implant, barrier methods with spermicide or abstinence). Females of non-childbearing potential are defined as post-menopausal (absence of menstrual bleeding for one year), hysterectomy, or bilateral oophorectomy. - Participants who are pregnant, planning to become pregnant or breastfeeding. A urine pregnancy test will be done to rule out pregnancy. - Immunosuppression - Participants who are HIV+ / Hepatitis B + / Hepatitis C+ - Participants who have been diagnosed or have a known history of any hematopathology disorders - Participants who have been diagnosed or have a known history of haemostasis disorders - Participants who have been diagnosed or have a known history of an autoimmune diseases - Participants who are undergoing chemotherapy - Participants with a history of any skin cancer on the scalp - Participants who have had skin biopsy or procedure on scalp in last month - Participants who have an implantable devices such as a deep brain stimulator in or other implantable device on or near treatment area - Non-English speakers |
Country | Name | City | State |
---|---|---|---|
United States | University of Minnesota | Minneapolis | Minnesota |
Lead Sponsor | Collaborator |
---|---|
University of Minnesota |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Scalp Health- Erythema | Primary endpoints will be changes in the Erythema score from baseline to Visit 8. Erythema score is a scale from 0 to 4. | Assessed at Visit 8 | |
Primary | Scalp Health- ASFS | Primary endpoints will be changes in the Adherent Scalp Flaking Score (ASFS) from baseline to Visit 8. ASFS is a scale 0 to 10. | Assessed at Visit 8 | |
Primary | Scalp Health- Folliculitis | Primary endpoints will be changes in the folliculitis score from baseline to Visit 8. Foliculitis score is a scale from 0 to 3. | Assessed at Visit 8 | |
Primary | Hair Changes | HairMetrix scale evaluates degree of improvement hair density, total hair count per sq cm and patient sensory assessment of scalp and hair from baseline to after each treatment and the follow up visit. The global assessment scales are a scale from 0 to 3. | Assessed at Visit 8 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06110377 -
MALE HAIR LOSS - Treatment With Dutasteride Mesotherapy x Dutasteride MMP Technique (Injections With Tattoo Machine)
|
Phase 4 | |
Recruiting |
NCT05611593 -
Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic Alopecia
|
Phase 1 | |
Completed |
NCT03676400 -
Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia
|
N/A | |
Recruiting |
NCT05938569 -
Computer-Assisted Hair Restoration Study Using ARTAS System
|
N/A | |
Not yet recruiting |
NCT06326359 -
Autologous Stromal Vascular Fraction in Treatment of Male Androgenic Alopecia
|
N/A | |
Recruiting |
NCT05369481 -
Comparison Between Efficacy of Topical Sildenafil 2% and Topical Minoxidil 5% in Treatment of Androgenic Alopecia
|
N/A | |
Recruiting |
NCT05827991 -
A Clinical Observation of 1565nm Non-ablative Fractional Laser in the Treatment of Androgenic Alopecia
|
N/A | |
Not yet recruiting |
NCT06292533 -
Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental Study
|
N/A | |
Completed |
NCT02824380 -
Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia
|
Phase 1 | |
Completed |
NCT06112782 -
Keravive by Hydrafacial for Scalp Health and Enhanced Hair Quality
|
N/A | |
Completed |
NCT02594046 -
The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia
|
N/A | |
Recruiting |
NCT05435625 -
Fractional Laser Versus Radiofrequency in Androgenetic Alopecia
|
N/A | |
Completed |
NCT05450861 -
Effect of the Composition From Fish on Promoting Hair Growth
|
N/A | |
Completed |
NCT03506503 -
Condensed Nanofat Grafting for Treatment of Androgenetic Alopecia
|
N/A | |
Completed |
NCT03467412 -
To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin
|
Phase 2 | |
Completed |
NCT01852487 -
Effect of Pumpkin Seed Oil on Hair Growth in Men With Androgenetic Alopecia
|
N/A | |
Not yet recruiting |
NCT03474718 -
Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia
|
Early Phase 1 | |
Active, not recruiting |
NCT02914587 -
Computer-Assisted Hair Implantation Using ARTAS System VS Manual Implantation Technique Hair Restoration Study
|
N/A | |
Completed |
NCT04341363 -
Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling
|
N/A | |
Completed |
NCT04450602 -
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
|
N/A |